$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Pulsed electric fields (PEFs) have grown to become a common tool for a variety of applications in biology and clinical applications1. These can be broadly categorized by electroporation (EP) and electrostimulation (ES). Electroporation has two subfields known as reversible and irreversible electroporation. Reversible electroporation (RE) has been used for decades as an effective tool for transferring molecular cargo such as plasmid DNA into cells of various types such as mammalian, bacterial, and yeast2. More recently, irreversible electroporation (IRE) has grown in prominence as a non-toxic alternative to current cancer treatments3. An emerging subfield is referred to as Pulsed Field Ablation (PFA), which focuses on non-thermal tissue removal, in particular for treating certain cardiac dysfunctions4. In combination with drugs and other reagents, this has led to the development of electrochemotherapy (ECT). However, the current understanding of PEF treatments is being outpaced by clinical applications5. Here we present an electroporation cytometry system for investigating electrochemotherapies. The cell cycle represents a key indicator of cell viability, and changes can identify phase-specific effects. By developing these tools, protocols can be adapted faster, providing more effective treatments for a wider range of cancers.
Our custom electrocytometry system (Figure 1) comprises a chamber with aluminum parallel plate electrodes and a coverglass bottom as well as a simple exponential decay pulse generator. The chamber is constructed from a 3D-printed chamber and a #1.5 cover glass bottom is affixed by medical-grade pressure-sensitive adhesive. Electrodes are formed from adhesive aluminum film placed over supports built into the chamber, providing two parallel electrodes 0.4 cm apart. This is a common configuration for commercial electrodes and provides a robust design that could quickly adapt current protocols. The chamber can fit within environmental enclosures designed for 25 mm x 55 mm slides, which is also a common slide format supported by commercial microscope providers. The pulse generator provides up to 330 V exponential decay pulses, allowing for a wide range of experiments to be achieved, including reversible and irreversible electroporation.
To study the effects of PEFs on the cell cycle, we used a transgenic human osteosarcoma cell line (U2 OS) expressing the Fluorescent Ubiquitination Cell Cycle Indicator (CA)5 (FUCCI(CA)5), a fluorescent live cell cycle reporter construct. The system introduces two fluorescent, truncated forms of Geminin and Cdt1, which are produced and recycled at specific rates during the cell cycle. Additionally, apoptosis can be directedly monitored during the experiment using a stably expressing FUCCI(CA)5 line of U2-OS cells. During the cell cycle, the reporter operates predictably with each phase because these are produced and degraded at the same rates as the functional versions naturally expressed in the cell. When apoptosis occurs, this cycle is disrupted with the cell cycle rapidly shutting down. Typically, this will manifest visually as the fluorescence staling within the cell cycle, followed by dramatic morphological changes to the nucleus, which is clearly visible due to the localization of the reporters to the nucleus6. This allows visual identification of each phase in single cells over time (Figure 2). Reversible electroporation causes changes to intracellular conditions and a 180 V exponential decay pulse was selected for investigation. This pulse was selected to limit cell death as much as possible, while ensuring electroporation in the majority of the population. This was determined based on prior research investigating optimal electroporation pulse parameters for six mammalian cell lines. The energy density of a 180 V pulse was slightly lower than the optimal transfection parameters, providing better cell viability with high poration7. The effect of the pulse was studied in unsynchronized cells and S-phase synchronized cells using a thymidine double block with and without PEF application (Figure 3). The results indicated a decrease in average length for S and G2 compared to control. This indicated that the S-phase was sensitive to PEF exposure resulting in a faster cell cycle. This demonstrated that the electroporation cytometry system was able to combine the delivery of PEFs with long-term live cell imaging for studying the cell cycle. While we used this platform to observe cell progression through the cell cycle in response to PEFs, this is a useful tool for studying a variety of applications and conditions for PEFs and cell culture.